From 2023 to 2033, the global takotsubo syndrome therapeutics market is expected to reach US$ 2.85 billion, with a compound annual growth rate (CAGR) of 6.1%. Takotsubo syndrome is a type of cardiovascular disease also known as stress cardiomyopathy and broken heart syndrome. FMI, in its business report, elaborates the historical and current scenario of …
Continue reading “Takotsubo Syndrome Therapeutics Market is expected to reach US$ 2.85 Bn in 2033”